These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


122 related items for PubMed ID: 8587061

  • 1. Intravenous cyclophosphamide pulses in the treatment of pyoderma gangrenosum associated with rheumatoid arthritis.
    Nordstrom D.
    J Rheumatol; 1995 May; 22(5):1000-1. PubMed ID: 8587061
    [No Abstract] [Full Text] [Related]

  • 2. Intravenous cyclophosphamide pulses in the treatment of pyoderma gangrenosum associated with rheumatoid arthritis: report of 2 cases and review of the literature.
    Zonana-Nacach A, Jiménez-Balderas FJ, Martínez-Osuna P, Mintz G.
    J Rheumatol; 1994 Jul; 21(7):1352-6. PubMed ID: 7966084
    [Abstract] [Full Text] [Related]

  • 3. Intravenous cyclophosphamide pulses in pyoderma gangrenosum: an open trial.
    Reynoso-von Drateln C, Perla-Navarro AV, Gamez-Nava JI, Gonzalez-Lopez L, Galvan-Villegas F, Ramos-Remus C.
    J Rheumatol; 1997 Apr; 24(4):689-93. PubMed ID: 9101503
    [Abstract] [Full Text] [Related]

  • 4. Use of infliximab in a patient with pyoderma gangrenosum and rheumatoid arthritis.
    Tada M, Nakanishi T, Hirata C, Okano T, Sugioka Y, Wakitani S, Nakamura H, Koike T.
    Mod Rheumatol; 2010 Dec; 20(6):598-601. PubMed ID: 20680379
    [Abstract] [Full Text] [Related]

  • 5. Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin-1 receptor antagonist anakinra.
    Brenner M, Ruzicka T, Plewig G, Thomas P, Herzer P.
    Br J Dermatol; 2009 Nov; 161(5):1199-201. PubMed ID: 19673875
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cyclosporin A in the treatment of rheumatoid associated pyoderma gangrenosum.
    Nisar M, Gawkrodger D, Bax D.
    Br J Rheumatol; 1995 Feb; 34(2):182. PubMed ID: 7704469
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Use of tocilizumab in a patient with pyoderma gangrenosum and rheumatoid arthritis.
    Lee WS, Choi YJ, Yoo WH.
    J Eur Acad Dermatol Venereol; 2017 Feb; 31(2):e75-e77. PubMed ID: 27325564
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Successful treatment of rheumatoid meningitis with cyclophosphamide but not infliximab.
    Chou RC, Henson JW, Tian D, Hedley-Whyte ET, Reginato AM.
    Ann Rheum Dis; 2006 Aug; 65(8):1114-6. PubMed ID: 16837495
    [No Abstract] [Full Text] [Related]

  • 15. A novel therapy for the treatment of pyoderma gangrenosum.
    Azizan NZ, Gangaram HB, Hussein SH.
    Med J Malaysia; 2008 Mar; 63(1):51-4. PubMed ID: 18935734
    [Abstract] [Full Text] [Related]

  • 16. B-cell lymphoma of the larynx in a patient with rheumatoid arthritis.
    Patiar S, Ramsden JD, Freeland AP.
    J Laryngol Otol; 2005 Aug; 119(8):646-8. PubMed ID: 16102224
    [Abstract] [Full Text] [Related]

  • 17. [Cyclophosphamide in the therapy of rheumatoid arthritis and its complications].
    Trefler J, Matyska-Piekarska E, Łacki JK.
    Pol Merkur Lekarski; 2007 Jun; 22(132):566-70. PubMed ID: 17874631
    [Abstract] [Full Text] [Related]

  • 18. Pyoderma gangrenosum possibly triggered by adalimumab.
    Kikuchi N, Hiraiwa T, Ohashi T, Hanami Y, Satoh M, Takenoshita H, Yamamoto T.
    Eur J Dermatol; 2012 Jun; 22(6):804-5. PubMed ID: 23107608
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Extensive Pyoderma Gangrenosum Associated With Granulomatosis With Polyangiitis With Both Responsive to Rituximab.
    Murthy RK, Jackson J, Chatham WW, Sami N.
    J Clin Rheumatol; 2016 Oct; 22(7):393-5. PubMed ID: 27660945
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.